Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26F5QMD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,394
Award facts
- Contract value 100% obligated
- $11,393.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 10, 2025, for the supply of Otezla (apremilast) 30 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $11,393.91 and an ultimate completion date of November 12, 2025. The award was competitively procured with no set-aside designation and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The Defense Logistics Agency Medical Supply Chain routinely issues delivery orders against its prime vendor contracts to fulfill pharmaceutical requirements across the Department of Defense and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Otezla is an immunosuppressive medication used to treat inflammatory conditions such as plaque psoriasis and psoriatic arthritis. This delivery order exemplifies AmerisourceBergen Drug Corp's established capability to meet federal procurement requirements for specialty medications within the DLA's pharmaceutical distribution network, supporting military medical readiness and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F5QMD?
SPE2DR26F5QMD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26F5QMD worth?
The government has obligated $11,394 on SPE2DR26F5QMD.
Is contract SPE2DR26F5QMD an order under another contract?
Yes. SPE2DR26F5QMD is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QMD competed?
The extent of competition for SPE2DR26F5QMD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award